Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study

We assessed the effect of a 2-year supplementation with a highly concentrated docosahexaenoic acid (DHA) product with antioxidant activity on non-proliferative diabetic retinopathy (NPDR) in a randomized double-blind placebo-controlled study. A total of 170 patients with diabetes were randomly assig...

Descripción completa

Detalles Bibliográficos
Autores principales: Piñas García, Purificación, Hernández Martínez, Francisco Javier, Aznárez López, Núria, Castillón Torre, Luis, Tena Sempere, Mª Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772895/
https://www.ncbi.nlm.nih.gov/pubmed/35052620
http://dx.doi.org/10.3390/antiox11010116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772895/
https://www.ncbi.nlm.nih.gov/pubmed/35052620
http://dx.doi.org/10.3390/antiox11010116

Ejemplares similares